About Automated Insulin Delivery Systems

What is an automated insulin delivery system?

An automated insulin delivery (AID) system is made up of an insulin pump, a continuous glucose monitoring (CGM) sensor, and predictive technology (an algorithm) that can predict glucose levels and automatically deliver or suspend insulin. Control-IQ+ technology is an advanced hybrid closed-loop system with predictive AutoBolus.

How an AID system works

CGM Data

The CGM delivers real-time glucose readings to the insulin pump via Bluetooth® connectivity.

Predictive Algorithm

Control-IQ+ uses those readings and determines whether to deliver or suspend insulin approximately every 5 minutes.

Insulin Pump

Provides a steady release of basal insulin throughout the day and allows for bolusing for meals.

Explore automated insulin delivery and how it works.

Learn More

Control-IQ+ Technology Tested. Trusted. Better.

Tandem pumps are now powered by Control-IQ+ — the only predictive algorithm with AutoBolus. It's our best algorithm yet!

Learn More

Best-In-Class Outcomes

Time in Range^1*

According to real-world results

Said it’s Easy to Use²

According to clinical study participants

Choose which Tandem automated insulin delivery system best fits your lifestyle.

Tandem Mobi System

This insulin pump can be worn almost anywhere,^† giving you more options for how you manage your diabetes. It’s powered by Control-IQ+ and is controllable with a compatible, personal iPhone.^‡

Explore Mobi

t:slim X2 Insulin Pump

Sleek and modern, this all-in-one pump is easy to use, has a color touchscreen, and it pairs with multiple CGM sensors.^§ It's powered by Control-IQ+, which predicts and helps prevent highs and lows.

Explore t:slim X2

Get started today!

A Tandem Diabetes Care Specialist will help you get started.

First Name

Last Name

Email Address

Zip or Postal Code

Phone Number

Consent

* With optimized Correction Factor based on “rule of less than 1600.”

† Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.

‡ The mobile app requires a compatible smartphone model and operating system (sold separately). Only available to pump users who reside in the United States.

§ CGM sold separately.

References

Note: Studies were conducted using a t:slim X2 insulin pump with Control-IQ technology and Dexcom G6.

1. Messer LH, Breton M. Diabetes Technol Ther. 2023;25(12):877-882.

2. Kudva YC, et al. Diabetes Technol Ther. 2021;23(10):673-683.

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.

Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.

Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.

Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin.  This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

Automated Insulin Delivery Automation for Better Control